Quell Therapeutics

Biotech & Life Sciences · London, United Kingdom · Founded 2019

Engineered T-regulatory cell therapies for immune-driven diseases

Valuation $500M–1B

Revenue $50–100M

Headcount 100–500

Unlock exact values

Power Law Colt$25–100M revenue

Talent graph

Quell Therapeutics's talent

Book a demo to see the people

Founders /100 quality score

Key operators quality score

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

17 investors on Quell Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

AlbionVC

UCL Technology Fund

Syncona

Series B+ 14 investors entered at this stage

Monashee Investment Management

Medizinische Hochschule Hannover

Ridgeback Capital

King's College London

British Patient Capital

Janus Henderson Investors

Breakthrough Energy Ventures

University College London

Future Fund

Jeito Capital

Fidelity Investments

SV Health Investors

Tekla Capital Management

Point72 Ventures

Ownership

Who owns Quell Therapeutics

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.

35.2% Syncona Limited

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Global footprint

Where Quell Therapeutics has talent and traffic

Workforce by country

🇬🇧 United Kingdom · London HQ

Book a demo for the full country breakdown

Web traffic by country

8.3K monthly visits
across markets

🇬🇧 United Kingdom41%

🇺🇸 United States37.3%

🇮🇳 India9.6%

🇯🇵 Japan6%

🇭🇷 Croatia4.8%

Top 5 markets shown

Market sentiment

What the market is saying about Quell Therapeutics

An AI-synthesized read of the highest-engagement posts about Quell Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Quell Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles